Rakuten Medical
PrivateLast Round
Series F
Jan 7, 2026
Est. Valuation
$1.2B
Total Funding Raised
$1.19B
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Rakuten Medical is a biotechnology company that develops precision-targeted cancer therapies aimed at treating solid tumors through the use of monoclonal antibody conjugates activated by light to selectively eliminate cancer cells while preserving healthy tissue.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Devices, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rakuten Medical Comparables
Compare Rakuten Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ImPact Biotech | 78% | |
| Aura Biosciences | 73% | |
| Illuminate Therapeutics | 69% |
Rakuten Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series F | Jan 7, 2026 | ||||
| Series E | Mar 6, 2024 | ||||
| Convertible Debt | Dec 1, 2022 | ||||
| Series D | Jul 28, 2021 | ||||
| Series C Extension | Jul 31, 2019 | ||||
Series C | Dec 20, 2018 |
Key People
Founding team and executive leadership
Rakuten Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Daiwa Securities Group | Series F |
| MS&AD Insurance Group Holdings | Series F |
| NEXUS CVC Partners Corporation | Series F |
| General Catalyst | Series D |
| ABIES Capital | Series F |
| Mitsui Sumitomo Insurance | Series F |
| Mizuho Bank, Ltd. | Series E |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
New preclinical findings presented at AACR 2026 on photoimmunotherapy platform.
- Apr 21, 2026
Presented new preclinical findings at the AACR 2026 conference.
Rakuten Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Rakuten Medical's valuation, stock price, and market status.
Is Rakuten Medical a public or private company?
Rakuten Medical is a private company.
What is the current stock price of Rakuten Medical?
Rakuten Medical is a private company with no public stock price. No recent secondary market data is available.
How much is Rakuten Medical worth (valuation)?
Valuation information for Rakuten Medical is not publicly available.
Can I buy Rakuten Medical stock?
Rakuten Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Rakuten Medical's last funding round?
Rakuten Medical's most recent funding round was Series F on January 7, 2026.
Who are the main investors in Rakuten Medical?
Key investors in Rakuten Medical include General Catalyst, Hikma Ventures.
Will Rakuten Medical IPO soon?
No public IPO plans have been announced for Rakuten Medical.
How can I track Rakuten Medical secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Rakuten Medical's secondary market activity and sign up for updates.